Tamsulosin STADA

Quick links

Choose a section

Quick links to important sections

Advertisements

Tamsulosin STADA

Advertisements

Overview of Tamsulosin STADA

Property Description
Active Ingredient Tamsulosin Hydrochloride
Form Modified-Release Capsules or Prolonged-Release Tablets
Pharmacological Class Alpha-Adrenergic Blocker (Alpha-1 Adrenoceptor Antagonist)
General Purpose To achieve smooth muscle relaxation for Urinary Flow Improvement
Origin Synthetic organic compound (Methoxybenzene Sulfonamide Derivative)

Tamsulosin STADA is a prescription-only medication chemically defined by its Active Ingredient, Tamsulosin Hydrochloride. This compound belongs to the Pharmacological Class known as Alpha-Adrenergic Blockers. The drug's general function is to achieve smooth muscle relaxation to help improve urine flow in men experiencing symptoms related to prostate enlargement. The active compound is a synthetic organic compound derived from the methoxybenzene sulfonamide group, distinguishing it by its specific molecular characteristics.

The Uroselective Nature of Tamsulosin

Tamsulosin is primarily characterized as a uroselective agent, meaning its Physiological Actions are highly concentrated on the receptors found in the lower urinary tract. This selectivity is crucial because it focuses the alpha-1 adrenoceptor antagonism on the bladder neck and prostatic urethra, which is where muscle tension causes obstruction. Tamsulosin is a highly selective alpha 1A-adrenoceptor antagonist. This high selectivity ensures the drug's effect is precisely focused on relieving obstruction in the urinary tract. By targeting these specific muscle groups, the compound acts to relieve muscle tension and facilitate better passage of urine.

The Role of Modified-Release Drug Forms

The pharmaceutical preparation Tamsulosin STADA is formulated as Modified-Release Capsules or Prolonged-Release Tablets, designed for Oral administration. This specialized Dosage Form is used to control the release of Tamsulosin Hydrochloride over an extended time period. The Modified-Release (MR) system ensures that the drug is supplied gradually and consistently into the body, which is essential for maintaining the continuous smooth muscle relaxation needed for sustained Urinary Flow Improvement throughout the day and night.

Advertisements

What side effects are possible with Tamsulosin STADA?

Possible side effects and safety information

The safety profile of Tamsulosin Hydrochloride is officially documented based on regulatory classifications, detailing known adverse reactions and specific constraints. Side effects are organized by frequency and the body system affected, according to standards set by government health authorities like the EMA and FDA.


Frequency-Classified Adverse Reactions

Adverse reactions are grouped by how often they are reported in clinical use:

Classification Documented Adverse Reactions (Examples)
Common (1 in 100 to 1 in 10 patients) Dizziness, Ejaculation disorders (such as retrograde ejaculation)
Uncommon (1 in 1,000 to 1 in 100 patients) Headache, Palpitations, Orthostatic Hypotension, Rhinitis, Gastrointestinal disturbances, Asthenia
Rare (1 in 10,000 to 1 in 1,000 patients) Syncope (fainting), Angioedema
Very Rare (less than 1 in 10,000 patients) Priapism, Stevens-Johnson Syndrome
Not Known (Post-marketing) Visual impairment, Atrial fibrillation, Arrhythmia, Dry mouth, Serious skin conditions

Safety Considerations and Constraints

Specific constraints and serious events are formally documented in official labeling:

  • Serious Adverse Reactions: Rare events include Angioedema (swelling) and the very rare occurrences of Priapism (a persistent, painful erection) and Stevens-Johnson Syndrome (a severe skin reaction).
  • Time-Related Pattern: Orthostatic Hypotension (a drop in blood pressure upon standing) is noted as an uncommon event that may occur, potentially leading to Syncope, particularly during the initiation of treatment.
  • Contraindications: The medicine is contraindicated (should not be used) in individuals with a known history of non-drug-induced Orthostatic Hypotension or Severe Hepatic Impairment (severe liver issues).
  • Surgical Risk: An association with Intraoperative Floppy Iris Syndrome (IFIS), a complication during cataract or glaucoma surgery, is officially documented and must be considered prior to ophthalmic procedures.
Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The primary documented manifestation of Tamsulosin overdose is acute hypotension, which is a severe drop in blood pressure. Other observed presentations may include vomiting and diarrhea. Due to the risk of severe symptomatic hypotension, immediate medical attention must be sought if an overdose is suspected, including contacting emergency services or a national poisons center.

The official management of overdose is defined as symptomatic and supportive treatment. To address acute hypotension, the initial required action involves placing the individual in a supine position (lying flat). Should blood pressure fail to stabilize with positioning, medical professionals may proceed with administration of intravenous fluids (volume expanders) and, if required, vasopressors.

In cases of recent, large over-ingestion, official procedural steps may include measures to impede absorption, such as gastric lavage or the administration of activated charcoal and an osmotic laxative. During management, continuous renal function monitoring is required. Regulatory labeling specifically notes that due to the high protein-binding of the drug, emergency procedures like dialysis are unlikely to be of benefit in treatment.

Advertisements

Therapeutic Uses of Tamsulosin STADA

What Tamsulosin STADA Treats: Main Uses and Benefits

Tamsulosin STADA may be part of symptomatic management for the lower urinary tract symptoms (LUTS) commonly associated with Benign Prostatic Hyperplasia (BPH), or an enlarged prostate, in adult men. It supports the moderation of distressing symptoms that may interfere with daily stability and quality of life, which contributes to easing the overall symptom load.


Addressing Voiding Symptoms and Flow

Tamsulosin STADA is applied in addressing symptoms that create noticeable functional strain, such as difficulty starting urination (hesitancy), having a weak or intermittent urine stream, and the uncomfortable feeling of incomplete bladder emptying. The general benefit is that it may assist with maintaining functional stability related to the urine stream and bladder comfort. It is commonly used when symptoms cluster into patterns requiring supportive management.


Support for Urgency and Frequency

The medication is used for managing irritative symptoms like urinary frequency, nocturia (waking up at night to urinate), and the sudden, compelling need to go (urinary urgency). Tamsulosin STADA contributes to easing the overall symptom load during difficult episodes, which may help improve day-to-day comfort during symptomatic periods.

Quick Fact: Relief for Voiding Symptoms The medication is commonly used to help with issues like a weak urine stream and difficulty starting the flow.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Tamsulosin STADA is officially intended for use only in adult males.

Populations Who Must NOT Use Tamsulosin STADA (Contraindications)

Based on regulatory documents, Tamsulosin STADA is contraindicated and must not be used by patients with the following conditions:

  • A known hypersensitivity or allergy to tamsulosin hydrochloride or any other component of the capsule, including a history of drug-induced angioedema.
  • A history of orthostatic hypotension, a form of low blood pressure that occurs upon standing, due to the risk of syncope (fainting).
  • Severe hepatic insufficiency (severe liver impairment).

Eligibility Restrictions and Limitations

Restriction Category Regulatory Status
Age and Sex Not indicated for use in women or in children and adolescents ( < 18 years), as safety and efficacy have not been established in the pediatric population.
Organ Impairment Use in patients with severe renal impairment (creatinine clearance < 10 ml/min) should be approached with caution as these patients have not been studied.
Scheduled Surgery Not recommended for patients scheduled for cataract or glaucoma surgery due to the risk of Intraoperative Floppy Iris Syndrome (IFIS).
Drug Combinations Should not be used in combination with strong inhibitors of CYP3A4 in patients who are known to be CYP2D6 poor metabolizers.

These restrictions define the boundaries of established and safe use, ranging from absolute prohibitions based on clinical history to cautions for populations where clinical data is insufficient or risk is documented.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documents classify the interaction profile of Tamsulosin Hydrochloride around metabolic and pharmacodynamic constraints. These constraints define specific prohibitions and cautions for co-administration with other substances.

Contraindicated Combinations

Co-administration with Strong Inhibitors of the CYP3A4 enzyme (such as Ketoconazole) is contraindicated. This is due to a pharmacokinetic interaction that results in a significant increase in the Area Under the Curve ( AUC) and Maximum Plasma Concentration ( C max) of Tamsulosin. Use with other Alpha-Adrenergic Blocking Agents is also contraindicated because of a pharmacodynamic interaction that heightens the risk of symptomatic hypotension.

Use with Caution and Exposure Effects

Caution is required when Tamsulosin is combined with Moderate Inhibitors of CYP3A4 (e.g., Erythromycin) or Strong Inhibitors of CYP2D6 (e.g., Paroxetine), as these combinations are documented to increase Tamsulosin exposure. The combination of Tamsulosin with Phosphodiesterase-5 (PDE5) Inhibitors (e.g., Sildenafil) requires caution due to the potential for an additive effect that may lead to symptomatic hypotension.

The regulatory profile notes that while co-administration with Cimetidine may raise Tamsulosin plasma levels and Furosemide may cause a fall in plasma levels, these changes are not officially deemed significant enough to require mandatory dosage adjustments.

Population and Substance Notes

The interaction profile includes a specific caution that patients who are CYP2D6 Poor Metabolizers should not use Tamsulosin concomitantly with Strong CYP3A4 inhibitors. The ingestion of substances that inhibit CYP3A4, such as grapefruit juice, may also raise the blood levels of Tamsulosin.

Advertisements

Mechanism of Action

The active ingredient, Tamsulosin, functions as a selective antagonist with high affinity that operates by precisely targeting key components of the autonomic nervous system within the lower urinary tract structures.

Selective Blockade of Alpha-1 Adrenoceptors

The drug's mechanism is centered on the competitive blockade of post-synaptic alpha-1 adrenoceptors (alpha1), particularly the alpha1A and alpha1D subtypes. These receptors are densely concentrated on the smooth muscle of the prostatic capsule and bladder neck. This action interrupts the natural signaling process where the neurotransmitter norepinephrine typically binds to and activates these receptors.

Modulating Dynamic Smooth Muscle Tone

By preventing norepinephrine binding, Tamsulosin inhibits the intracellular signaling cascade that would otherwise trigger smooth muscle contraction. The resulting physiological effect is a reduction of muscle tone within the structures that surround the urethra. This mechanism operates only on the dynamic component (muscle tension), decreasing internal pressure without influencing the structural size or volume of the gland.

Advertisements

Dosage and Administration Information

The administration of Tamsulosin STADA must strictly follow the official instructions for its modified-release formulation. The medicine is for oral use only.

Official Dosing and Administration

Guideline Instruction
Recommended Dose 0.4 mg once daily.
Dose Adjustment May be increased to 0.8 mg once daily if response to the 0.4 mg dose is inadequate after 2 to 4 weeks.
Timing Administer approximately one-half hour following the same meal each day (e.g., after breakfast). Some prolonged-release tablets may be taken independently of food.
Preparation The capsule or prolonged-release tablet must be swallowed whole. Do not crush, chew, or open, as this will interfere with the modified/prolonged release mechanism.

Rules for Specific Use

Missed Dose: If administration is discontinued or interrupted for several days, therapy should be started again with the 0.4 mg once-daily dose. Do not take a double dose to make up for a forgotten dose.

Age Restrictions: The safety and efficacy of tamsulosin in children and adolescents under 18 years have not been established; there is no relevant indication for use in this population.

Renal/Hepatic Status: No dose adjustment is warranted for patients with renal impairment or mild to moderate hepatic insufficiency. Caution is advised for those with severe renal impairment (creatinine clearance <10 mL/min).

Monitoring: Digital rectal examination and Prostate-Specific Antigen (PSA) determination should be performed before initiating treatment and at regular intervals afterward to exclude other conditions.

Administration Method: Oral, once-daily dosing with food (or after the first meal) is the established procedure for the correct systemic delivery of the active substance.

Advertisements

Recent Clinical Evidence

Tamsulosin STADA: Recent Clinical Evidence

Phase 3 Trials: Research Focus

Clinical data on Tamsulosin are drawn primarily from large-scale, placebo-controlled Phase 3 randomized controlled trials (RCTs). These studies were designed to assess the compound in men with lower urinary tract symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH). The investigation focused on key measures such as the International Prostate Symptom Score (IPSS) and peak urinary flow rate (Qmax).

  • Trial Findings: Trials spanning 12 to 13 weeks reported statistically significant differences between the active treatment groups and placebo in terms of IPSS and Qmax. A greater proportion of patients receiving the drug reported a clinically relevant difference in measured symptoms compared to the placebo group.

Long-Term Efficacy and Safety Profile

Long-term data collection, including extension studies lasting up to six years, has been conducted to observe the sustained profile of the compound.

  • Sustained Observations: Significant improvements in IPSS and Qmax observed after the initial treatment period were reported to be sustained throughout the years of follow-up for the observed patient cohorts.
  • Safety Observations: Tamsulosin has demonstrated a favorable safety profile concerning cardiovascular effects. In clinical trials, the compound was not associated with clinically significant changes in blood pressure compared to placebo. The most commonly reported side effects included dizziness and abnormal ejaculation.
Observation Period Symptom Score (IPSS) Change vs. Baseline Max. Flow Rate (Qmax) Change vs. Baseline
3 Months (Short-term) Significant improvement observed Significant increase observed
Up to 6 Years (Long-term) Improvement reportedly maintained Increase reportedly maintained
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Tamsulosin STADA (FAQ)

Q: Is Tamsulosin STADA the same as Flomax?

Flomax is a recognized brand name for the active ingredient tamsulosin hydrochloride. Tamsulosin STADA is another pharmaceutical preparation that contains this exact same active substance. Official medical information and established effects are entirely focused on the drug substance, tamsulosin, which is consistent across both the brand-name product and generic versions like Tamsulosin STADA.


Q: Will Tamsulosin STADA shrink the prostate?

Tamsulosin STADA is described as working by relaxing the smooth muscle in the prostate and bladder neck to relieve pressure and improve urine flow. This action addresses the muscle tension, known as the dynamic component of the symptoms. Regulatory documents indicate that the drug's mechanism does not influence the physical size or volume of the prostate gland itself.


Q: What is the difference between Tamsulosin and other BPH drugs?

Tamsulosin belongs to the class of alpha-1 adrenergic blockers, which work primarily by muscle relaxation to improve urinary flow. Other medications for Benign Prostatic Hyperplasia (BPH), such as 5-alpha reductase inhibitors (like finasteride), have a different mechanism; they work to reduce the physical size of the enlarged prostate gland over time.


Q: Is Tamsulosin STADA used for kidney stones?

The primary official indication for Tamsulosin STADA is to treat the urinary symptoms associated with Benign Prostatic Hyperplasia (BPH). Use of the drug for conditions other than BPH, such as assisting with the passage of kidney stones (known as Medical Expulsive Therapy), is not the approved purpose defined in official regulatory documents.


Q: How long does it usually take for Tamsulosin STADA to start working?

While the maximum benefit is observed over several weeks of continuous use, the muscle relaxation effect can begin relatively quickly after starting the medication. Clinical studies typically assess the full effectiveness of the drug over a period of 4 to 12 weeks of continuous use, showing significant improvements compared to placebo within that time.


Q: Is it normal to feel dizzy or lightheaded after starting Tamsulosin STADA?

Dizziness is a common side effect, and a feeling of lightheadedness upon standing, caused by a drop in blood pressure (Orthostatic Hypotension), is an uncommon side effect. Regulatory documents state that this change in blood pressure may occur, particularly upon the initiation of treatment or following a dose increase.


Q: Can I take Tamsulosin STADA if I am already taking blood pressure medication?

Regulatory documents state that no mandatory dosage adjustments are needed when tamsulosin is combined with certain specific blood pressure medications. However, the use of Tamsulosin STADA with other alpha-adrenergic blocking agents is contraindicated (should not be used) because this combination heightens the risk of symptomatic low blood pressure.


Q: Are there any reported interactions with alcohol and Tamsulosin STADA?

The interaction profile notes that alcohol consumption may contribute to the drug's blood pressure-lowering effect. This potential interaction could increase the risk of side effects such as dizziness or lightheadedness, especially when changing position from sitting or lying down.


Q: Can Tamsulosin STADA be taken with supplements or herbal remedies?

Tamsulosin is processed by specific liver enzymes, primarily CYP3A4. Regulatory documents caution that substances which inhibit this enzyme, such as certain components found in grapefruit juice, may raise the level of tamsulosin in the blood. Official guidance suggests that the use of supplements or herbal remedies should be discussed with a healthcare professional.


Q: Why do doctors recommend taking Tamsulosin STADA at the same time each day?

The instruction to take the medicine after the same meal each day is essential because Tamsulosin STADA is a modified-release formulation. This controlled timing helps ensure a consistent and steady level of the active ingredient is maintained in the bloodstream. This stable concentration is needed for the drug to provide continuous smooth muscle relaxation throughout the 24-hour period.


Q: Can Tamsulosin STADA affect my ability to drive or operate machinery?

Because the drug can cause side effects such as dizziness and, in rare instances, fainting (syncope), regulatory labels contain a caution that patients should be aware of how the medicine affects them before engaging in driving or operating machinery, particularly when starting treatment or if the dose is changed.


Q: Can Tamsulosin STADA affect the results of lab tests?

Regulatory documents indicate that treatment with tamsulosin has no significant effect on Prostate-Specific Antigen (PSA) levels. Unlike some other BPH drugs, Tamsulosin does not require adjustment of PSA results for interpretation when a patient is being monitored for prostate health.


Q: What is the risk of a serious allergic reaction to Tamsulosin STADA?

The risk of a serious allergic reaction, such as a severe swelling of the face, lips, or throat known as Angioedema, is classified as rare in official regulatory reporting. Even rarer events, occurring in less than 1 in 10,000 patients, include conditions like Stevens-Johnson Syndrome.


Q: What should I know about taking Tamsulosin STADA if I have a history of heart issues?

Although Tamsulosin is generally not associated with clinically significant changes in blood pressure, it can cause symptoms of orthostasis (low blood pressure upon standing). Some regulatory information suggests caution in patients with a history of certain heart issues or those who are predisposed to hypotension (low blood pressure). The use of the drug in these instances requires medical review.


Q: Is Tamsulosin STADA suitable for people with diabetes?

Official documents note that tamsulosin may be associated with increased blood glucose levels in some users. Official information indicates that monitoring of blood glucose levels may be necessary for patients with diabetes, particularly when starting the medication or if the dosage is adjusted.


Q: What should I know about taking Tamsulosin STADA if I have liver problems?

Tamsulosin is contraindicated (should not be used) in patients with a diagnosis of severe hepatic insufficiency (severe liver issues). However, official guidelines state that for individuals with mild to moderate liver impairment, a dosage adjustment is typically not required.


Q: Can Tamsulosin STADA cause headaches or sinus issues?

Yes, official documentation lists headache as a documented adverse event from clinical trials. Additionally, symptoms related to sinus issues, such as rhinitis (a stuffy or runny nose), are also listed as an uncommon adverse reaction associated with Tamsulosin STADA.


Q: Does Tamsulosin STADA cause weight gain?

Weight gain is not listed among the commonly reported side effects or adverse reactions in the official prescribing information for Tamsulosin STADA found in regulatory documents.


Q: Does Tamsulosin STADA affect fertility in men?

Tamsulosin is officially known to cause abnormal ejaculation, such as a decrease in semen volume or inability to ejaculate (anejaculation). The FDA label states that the effects of tamsulosin on the ability to have children have not been definitively evaluated in humans.


Q: Is Tamsulosin STADA considered a safe option for BPH treatment?

Tamsulosin is an established and officially approved treatment option for symptoms related to Benign Prostatic Hyperplasia. Regulatory authorities have comprehensively documented its safety profile, which includes a list of known side effects, contraindications, and warnings. It is considered a safe option when used within these established constraints.


Q: Do many people stop taking Tamsulosin STADA because of side effects?

Official documents do not provide specific numbers on how many people stop taking the drug outside of clinical trials. However, data from clinical trials reported an adverse event-related withdrawal rate of approximately 5% to 7% for the 0.4 mg dose. Dizziness and ejaculation disorders are the most frequently reported common side effects.


Q: Why do some people take Tamsulosin STADA in the evening?

The official instruction is to take the medicine after the same meal each day, which could be dinner. This choice is often due to patient preference to ensure consistency or to manage potential side effects like dizziness, which may be less noticeable if taken closer to bedtime. The drug has also been noted in research to improve sleep disturbed by urinary frequency (nocturia).


Q: Is it okay to stop taking Tamsulosin STADA suddenly?

Official instructions advise that if administration is discontinued for several days, therapy should be restarted at the initial dose. It is generally understood that the return of urinary symptoms is likely if the medication is stopped. The instruction for interrupted therapy is to restart at the initial dose.


Q: Is there a rebound effect if you stop taking Tamsulosin STADA?

Official regulatory documents do not specifically use the term 'rebound effect.' However, because the drug only works to relieve muscle tension in the urinary tract, the BPH symptoms that the drug was managing would be expected to return or worsen once the medication is stopped.


Q: What should I do if a side effect seems serious?

Regulatory information lists serious adverse events, such as a prolonged, painful erection (Priapism) or signs of a severe allergic reaction (Angioedema). In the event a serious side effect is suspected, official regulatory information directs that immediate medical attention is necessary.


Q: Does Tamsulosin STADA help with bladder pain, or just urination issues?

The official indication for Tamsulosin STADA is focused on the treatment of urinary flow symptoms associated with BPH, such as hesitancy, weak stream, and incomplete emptying. Bladder pain is not listed as a specific symptom or condition that Tamsulosin is officially indicated to treat.


Q: How is Tamsulosin STADA different from Finasteride?

Tamsulosin is categorized as an alpha-1 adrenergic blocker that works by relaxing the smooth muscles of the lower urinary tract to improve flow. Finasteride belongs to a separate class, 5-alpha reductase inhibitors, which works through a hormonal mechanism to reduce the physical size of the enlarged prostate gland.


Q: Is there a maximum age limit for taking Tamsulosin STADA?

Official documentation states that the safety and efficacy of the drug have not been established in children and adolescents (under 18 years). There is no maximum age limit for use in adult males defined in the official prescribing information, with use determined by individual medical status.

Advertisements

How should Tamsulosin STADA be stored and disposed of?

How to Store and Dispose of Tamsulosin STADA

Official regulatory guidelines define specific conditions for storing and disposing of Tamsulosin STADA capsules. The medicine must be stored at Controlled Room Temperature, ideally between 20 C and 25 C (68 F and 77 F). The product must be kept in the original container, tightly closed, and stored away from excess heat and moisture, which typically means avoiding storage in a bathroom.

For safety, the medication must be stored out of the sight and reach of children, often requiring a locked safety cap. Disposal of unused or expired Tamsulosin STADA should utilize an official drug take-back program. If such a program is unavailable, follow instructions to mix the capsules with an undesirable substance before discarding them in the household trash. Do not flush this medicine down a toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tamsulosin STADA found in:

A-Z Index: